INDIANAPOLIS, Oct. 5, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from several studies which further reinforce the advancement of its diverse clinical cancer portfolio during the European Society of Medical Oncology's ... 4 Traders, 2 weeks ago
Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016 - Presentation Master, 2 weeks ago
Eli Lilly Highlights Advancements In Its Oncology Portfolio With New Data At - BioSpace, 2 weeks ago
Hungry to succeed, Ori Yehudai is building Frutarom into a global flavors giant, very much his way. Vertigo. That' s the feeling aroused by following Ori Yehudai's career at Frutarom Industries Ltd. (TASE: FRUT ; LSE: FRUT ; OTCBB:FRUTF). He ...Globes, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!